A Study to Investigate the Effect of Multiple Doses of Danoprevir/Ritonavir (DNV/RTV) on the Pharmacokinetics (PK) of Escitalopram (ESC) and S-Demethylcitalopram (S-DCT) in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Danoprevir (Primary) ; Ritonavir (Primary) ; Escitalopram
- Indications Generalised anxiety disorder; Hepatitis C; HIV infections; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Social phobia
- Focus Pharmacokinetics
- Sponsors Roche
- 16 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Dec 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Dec 2011 Planned End Date changed from 31 Aug 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.